Company intelligence / Profile preview

Artemida Clinical

Ownership: Private
Employees: ~24
Development stage: Other

Overview

Artemida Pharma is a specialist drug development consultancy providing strategic advice and project management to biotech, pharma startups, and mid-sized companies. They offer end-to-end services from preclinical through commercialization with expertise in small molecules and biologics. Their team has decades of experience across multiple therapeutic areas including oncology, rare diseases, and cardiovascular disease. They have received the Queen’s Award for Enterprise in International Trade for their outstanding business performance.

Therapeutic areas: OncologyCardiovascularRare Diseases
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

ShiftZeroMember of Oslo Cancer Cluster

Beyond the preview

Go deeper on Artemida Clinical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artemida Clinical.

Explore the full profile